Type your tag names separated by a space and hit enter

Polycystic Ovarian Syndrome (PCOS)

Polycystic Ovarian Syndrome (PCOS) is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • Polycystic ovarian syndrome (PCOS) is a common endocrine disorder with heterogeneous manifestations that affects 6–10% of the U.S. population.
  • Hyperandrogenism, insulin resistance, and anovulation, typically presenting as amenorrhea or oligomenorrhea
  • Diagnostic clinical characteristics include menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. The ovaries are often polycystic on imaging.
  • The etiology of PCOS is unknown but can be modified by lifestyle factors.
  • System(s) affected: reproductive, endocrine/metabolic, skin/exocrine
  • Synonym(s): Stein-Leventhal syndrome; polycystic ovary disease
ALERT
  • Condition may begin at puberty.
  • Predisposes to and is associated with obesity, hypertension, diabetes, metabolic syndrome, hyperlipidemia, infertility, insulin-resistance syndrome, endometrial hyperplasia, and uterine cancer
  • In the United States, 40% of women with PCOS are not obese.

Epidemiology

Prevalence
  • Incidence and prevalence are still highly debated due to a wide spectrum of diagnostic features: The National Institutes of Health (NIH) criteria require chronic anovulation in addition to clinical or biochemical signs of hyperandrogenism. The prevalence based on NIH criteria is 6.5–8%.
  • Predominant age: reproductive age
  • Predominant sex: females only

Etiology and Pathophysiology

  • PCOS is a multifactorial functional disorder of unclear etiology.
  • Recent evidence points to a primary role for insulin resistance with hyperinsulinemia.
  • Increased GnRH pulsations in the hypothalamus lead to increased production of luteinizing hormone (LH) with limited production of FSH.
  • Hyperandrogenism: Ovaries are the main source of excess androgens. Polycystic ovaries have thickened thecal layers, which secrete excess androgens in response to LH. LH receptors are overexpressed in thecal and granulosa cells of polycystic ovaries.
  • Ovarian follicles: Abnormal androgen signaling may account for abnormal folliculogenesis causing polycystic ovaries.
  • Insulin resistance: Women with PCOS have insulin resistance similar to that in type 2 diabetes. Elevated levels of insulin decrease sex hormone–binding globulin (SHBG), increasing bioavailability of testosterone. Insulin may also act directly on adrenal glands, ovaries, and hypothalamus to enhance androgen production. Insulin resistance also causes elevated insulin levels.
  • Insulin resistance may cause the frequently associated metabolic syndrome and frank diabetes mellitus.

Genetics
  • Likely a combination of polygenic and environmental factors
  • Implicated genes include DENND1A and THADA.

Risk Factors

See “Commonly Associated Conditions”; cause and effect are difficult to extricate in this disorder.

General Prevention

None known; focus on early diagnosis and treatment to prevent long-term complications.

Commonly Associated Conditions

  • Infertility
  • Obesity
  • Obstructive sleep apnea
  • Hypertension
  • Diabetes mellitus
  • Endometrial hyperplasia/carcinoma
  • Fatty liver disease
  • Mood disturbances and depression
  • Hirsutism

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Stephens, Mark B., et al., editors. "Polycystic Ovarian Syndrome (PCOS)." 5-Minute Clinical Consult, 27th ed., Wolters Kluwer, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816808/all/Polycystic_Ovarian_Syndrome__PCOS_.
Polycystic Ovarian Syndrome (PCOS). In: Stephens MB, Golding J, Baldor RA, et al, eds. 5-Minute Clinical Consult. 27th ed. Wolters Kluwer; 2019. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816808/all/Polycystic_Ovarian_Syndrome__PCOS_. Accessed March 26, 2019.
Polycystic Ovarian Syndrome (PCOS). (2019). In Stephens, M. B., Golding, J., Baldor, R. A., & Domino, F. J. (Eds.), 5-Minute Clinical Consult. Available from https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816808/all/Polycystic_Ovarian_Syndrome__PCOS_
Polycystic Ovarian Syndrome (PCOS) [Internet]. In: Stephens MB, Golding J, Baldor RA, Domino FJ, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2019. [cited 2019 March 26]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816808/all/Polycystic_Ovarian_Syndrome__PCOS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Polycystic Ovarian Syndrome (PCOS) ID - 816808 ED - Stephens,Mark B, ED - Golding,Jeremy, ED - Baldor,Robert A, ED - Domino,Frank J, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816808/all/Polycystic_Ovarian_Syndrome__PCOS_ PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -